{"name":"Gang Wang","slug":"gang-wang","ticker":"","exchange":"","domain":"","description":"","hq":"","founded":0,"employees":"","ceo":"","sector":"","stockPrice":0,"stockChange":0,"stockChangePercent":0,"marketCap":"","metrics":{"revenue":0,"revenueGrowth":0,"grossMargin":0,"rdSpend":0,"netIncome":0,"cash":0,"dividendYield":0,"peRatio":0,"fiscalYear":"FY2026"},"revenueBreakdown":[],"timeline":[{"date":"2026-07-28","label":"Q2 2026 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2026-10-28","label":"Q3 2026 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-01-28","label":"Q4 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-04-28","label":"Q1 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-07-28","label":"Q2 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-10-28","label":"Q3 2027 Earnings","type":"earnings","sentiment":"neutral"}],"diseaseAreas":[],"pipeline":[],"recentEvents":[],"realNews":[{"url":"https://news.google.com/rss/articles/CBMiakFVX3lxTE9jVTNGeERFdWh5M3VfNXB1RjFQZ3gzVTFWdWlFVlM4Rm9LdHU1S3pnM3o0RjM4VzdqTVRqYS1jLTlNYzBVNzdCZzlwTHBTZjZmdHNmekIzeW4tVkRLYkV6OS15eXlETm5YVmc?oc=5","date":"2025-08-13","type":"pipeline","source":"Wiley Online Library","summary":"Ru-Catalyzed Asymmetric Reductive Amination of Benzyl Ketones: Asymmetric Control Enabled by Synergistic Interaction of Both Chiral Bisphosphine and Chiral Amino-Acid Ligands - Wiley Online Library","headline":"Ru-Catalyzed Asymmetric Reductive Amination of Benzyl Ketones: Asymmetric Control Enabled by Synergistic Interaction of ","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMiX0FVX3lxTE9CdS1SZEZqbENVVnhtZ1I1T3ExYkRsYlJhVktXRDZOS2lnNmd5VzRzcmVxUjV2TmlvSVV1WFJaODliMlg5Um82V1hQcUNwT0lJV3pCaERiOHpjODJUeHJr?oc=5","date":"2025-04-04","type":"pipeline","source":"Nature","summary":"Defying the oxidative-addition prerequisite in cross-coupling through artful single-atom catalysts - Nature","headline":"Defying the oxidative-addition prerequisite in cross-coupling through artful single-atom catalysts","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMiwgFBVV95cUxNZWtSaDRwTEd5Uy1NemNSNjdXbGFUdDM2TFo4QWQwR0lRckdiaTV4YlRWMEdpQ2U2WVFoblhLY3B4S0g5N3F3SVZtU1FzMGtyUk1oeEJoNUM2UUpNblprdUtERkhXNU8xS2pZTGZ3ZTRKZjFFQkFzU1ZQWURCa081SUZiUFlLdTVEa1I5Sy1GWmxOTWN3eUdhc24zS0lfLXdJSlFBVTlBdllOYjJyYU1DUFdMNzZFVlpGbWF1SU4zaHJ3QQ?oc=5","date":"2024-05-13","type":"pipeline","source":"NBC News","summary":"Trump suggests Chinese migrants came to U.S. to build an ‘army.’ Migrants share actual reasons they came. - NBC News","headline":"Trump suggests Chinese migrants came to U.S. to build an ‘army.’ Migrants share actual reasons they came.","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMi1wFBVV95cUxQSDQydWxUd0ljNHNSaEtKQkpnRXVCcDg5TzdOdHhsY19xdGRnOWJfN3AwNDVMbDBrbjVjNnJGNm1keE5MTklNTEhja18xVUVtNHZfQWNwZjlxVmVUZy1rNEVCRTQtX2ZEYy1PcXBFN3QwTy1jRVZFMGZtUHpJbk10cXRwMFZiR2JZZlZvazlheVhRbGNETnpHdkVRSXQyOG5TR09fbHkyUERhVi1QakNYaU5qbVFIMkRaaTZKMTRaWmFnYjBNOEFuVnVsMExXaDAzLVM0TXBNaw?oc=5","date":"2021-07-29","type":"pipeline","source":"The US-China Business Council","summary":"Week in Review: Sherman-Wang Meeting, Qin Gang Arrives in DC, and Huawei Prosecutor to Oversee Export Controls - The US-China Business Council","headline":"Week in Review: Sherman-Wang Meeting, Qin Gang Arrives in DC, and Huawei Prosecutor to Oversee Export Controls - The US","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMiZ0FVX3lxTE1iVXF0QXFsQkhKczdWeDgyeWMyNjZzQVNUNXRTbWZEY0hrd1VpRUlXX2thc21uVXJKYk5xamMyOXJXS1JhNjJSQ0tDejNYT0dQcEhOZGt2d1V1VnlhcDNNVVJhWjFNM28?oc=5","date":"2021-04-23","type":"pipeline","source":"ACS Publications","summary":"Highly Enantioselective Direct Asymmetric Reductive Amination of 2-Acetyl-6-Substituted Pyridines | Organic Letters - ACS Publications","headline":"Highly Enantioselective Direct Asymmetric Reductive Amination of 2-Acetyl-6-Substituted Pyridines | Organic Letters","sentiment":"neutral"}],"patents":[],"drugCount":0,"phaseCounts":{},"enrichmentLevel":0,"visitCount":1,"keyCompetitors":[],"therapeuticFocus":[],"financials":null,"yahoo":null}